Potent Antitumor Activity of Ensartinib in MET Exon 14 Skipping-Mutated Non-Small Cell Lung Cancer.
Cancer Letters（2023）
Key words
MET inhibitor,NSCLC,MET exon 14 skipping mutation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined